Overview

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Status:
Terminated

Trial end date:
2013-04-15

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine the effectiveness of an investigational drug called lucanthone, when combined with temozolomide (TMZ) and radiation in the treatment of Glioblastoma Multiforme (GBM).

Phase:

Phase 2

Details

Lead Sponsor:

Spectrum Pharmaceuticals, Inc

Treatments:

Dacarbazine
Lucanthone
Temozolomide